Short communicationPublished 29 Jan 2021

C-reactive proteins has the potential to inhibit

Authors: Garu

Journal of Organic & Inorganic Chemistry

Volume 7 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

C-reactive protein (CRP) is an acute phase reactant mainly produced in the liver in response to elevated levels of interleukin-1β (IL-1β) and IL-6. Its clinical relevance as an indicator of inflammation is outstanding but the biological functions are poorly defined. CRP belongs to the family of pentraxins and calcium-dependently binds ligands containing a phosphocholine head-group. We demonstrate that CRP isolated from human bodily fluids is an unconventional agonist of monocytic nicotinic acetylcholine receptors (nAChR) containing subunits α7, α9 and α10. Marginally pathologic CRP levels (IC50 = 4.9 mg/l) efficiently inhibit ATP-dependent NLRP3 inflammasome activation and IL-1β maturation by human monocytic cells.

Keywords

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Organic & Inorganic Chemistry.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Organic & Inorganic Chemistry
  • SubjectChemistry
  • BylineArticles whose byline prints “Garu”